Abstract
SAFE-DCB is a prospective, multi-center registry designed to assess patient outcomes and safety following the use of the Lutonix® paclitaxel-coated angioplasty balloon (DCB) for the treatment of de-novo or restenotic lesions (non-stent) in the superficial femoral (SFA) or popliteal arteries (PA) in
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
